CSIMarket
 
Zomedica Corp   (NONE: ZOMDF)
 

Zomedica's Customers Performance

ZOMDF



 
ZOMDF's Source of Revenues During the corresponding time, Zomedica Corp recorded a revenue increase by 32.42 % year on year, sequentially revenue fell by -18.98 %. While revenue at the Zomedica Corp 's corporate clients

List of ZOMDF Customers




for the same period Zomedica Corp recorded revenue increase by 32.42 % year on year, sequentially revenue fell by -18.98 %.

List of ZOMDF Customers

Zomedica's Business Units
Capital    23.27 % of total Revenue
Consumables    64.47 % of total Revenue
Engineering    14.66 % of total Revenue
Other    1.31 % of total Revenue
Diagnostics    11.39 % of total Revenue
Diagnostics Capital    1.97 % of total Revenue
Diagnostics Consumables    9.42 % of total Revenue
Therapeutic Devices    68.61 % of total Revenue
Therapeutic Devices Capital    16.89 % of total Revenue
Therapeutic Devices Consumables    51.5 % of total Revenue
Therapeutic Devices Other    0.22 % of total Revenue
Development Services    23.72 % of total Revenue
Development Services Capital    4.41 % of total Revenue
Development Services Consumables    3.56 % of total Revenue
Development Services Engineering    14.66 % of total Revenue
Development Services Other    1.08 % of total Revenue
US    87.02 % of total Revenue
Foreign countries    16.69 % of total Revenue






Zomedica's Comment on Sales, Marketing and Customers



The company provides diagnostic and therapeutic technologies to veterinarians and pet owners, focusing on enhancing pet care quality, customer satisfaction, and veterinary practice efficiency. Its market includes domestic animal health distributors, online retailers, and international subsidiaries and distribution channels. The company offers six product lines of diagnostic and therapeutic devices, including the TRUFORMA Bulk Acoustic Wave point-of-care diagnostic platform, which features assays for feline optimized TSH, canine endogenous ACTH, canine Free T4, a multiplex cartridge for canine and feline cobalamin and folate, equine endogenous ACTH, canine NT-proBNP, canine progesterone, equine insulin, equine cortisol, and canine TSH. Additional products include the VETGuardian PLUS Zero Touch vital signs remote monitoring system, the TRUVIEW digital microscopy platform, and VETIGEL, a hemostatic gel licensed from Cresilon, Inc. The company serves veterinarians and pet owners through multiple purchasing channels and seeks to expand its revenue and product portfolio through acquisitions and internal development.





Zomedica’s Comment on Sales, Marketing and Customers


The company provides diagnostic and therapeutic technologies to veterinarians and pet owners, focusing on enhancing pet care quality, customer satisfaction, and veterinary practice efficiency. Its market includes domestic animal health distributors, online retailers, and international subsidiaries and distribution channels. The company offers six product lines of diagnostic and therapeutic devices, including the TRUFORMA Bulk Acoustic Wave point-of-care diagnostic platform, which features assays for feline optimized TSH, canine endogenous ACTH, canine Free T4, a multiplex cartridge for canine and feline cobalamin and folate, equine endogenous ACTH, canine NT-proBNP, canine progesterone, equine insulin, equine cortisol, and canine TSH. Additional products include the VETGuardian PLUS Zero Touch vital signs remote monitoring system, the TRUVIEW digital microscopy platform, and VETIGEL, a hemostatic gel licensed from Cresilon, Inc. The company serves veterinarians and pet owners through multiple purchasing channels and seeks to expand its revenue and product portfolio through acquisitions and internal development.








ZOMDF's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Zomedica Corp 81.43 34.10 -79.70 141
SUBTOTAL 0.00 0.00 0.00 -

Sources: Zomedica Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Zomedica Corp’s corporate clients.
For your research, we’ve provided 9 tables on Zomedica Corp corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.